Advisory: Alert on Aptose Biosciences' selling shareholders offering withdrawn
An alert referring to stock offering by selling stockholders of
Aptose Biosciences APS.TO is wrong and has been withdrawn.
The alert was framed off a filing from an unrelated company,
Atif Holdings Ltd. For the alert on Atif Holdings, click
urn:newsml:reuters.com:*:nFWN2JH0YA.
STORY_NUMBER: FWN2JH0Y9
STORY_DATE: 06/01/2021
STORY_TIME: 10:17:45
((bangalore.newsroom@thomsonreuters.com))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting